Related Experiment Video
Updated: Dec 12, 2025

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Fatal Prosthetic Valve Endocarditis Due to Aspergillus flavus in a Diabetic Patient
Rozita Jalalian1, Tahereh Shokohi2,3, Roghayeh Mirzakhani4
1Department of Cardiology, Mazandaran University of Medical Sciences, Sari, Iran.
Abstract:
Aspergillus endocarditis (AE) accounts for a-quarter of all fungal endocarditis, mainly in immunocompromised hosts prior to heart-valve surgery with high mortality, even with treatment. Herein, we report a rare case of AE in a diabetic 60-year-old woman with a history of redo mitral valve prosthesis suspecious of acute endocarditis. She underwent second redo surgical mitral valve replacement in combination with mechanical aortic valve replacement. Blood cultures were negative. The explanted valve and vegetation were subjected to identification. Grown colonies were identified as Aspergillus flavus, based on conventional and molecular methods. Despite the administration of liposomal amphotericin B and improvement in her general condition shortly after initiation of therapy, the patient passed away. As AE is a late consequence of redo prosthetic valve replacement, extended follow-up, early diagnosis, repeating valve-replacement surgeries, and timely selective antifungal treatments are warranted.
Insights
This case report details Aspergillus endocarditis (AE) in a patient with a prosthetic valve. Despite treatment, the patient succumbed, highlighting the critical need for vigilance in managing fungal endocarditis.
Area of Science:
- Cardiology
- Infectious Diseases
- Mycology
Background:
- Aspergillus endocarditis (AE) is a severe complication, particularly in immunocompromised individuals undergoing heart valve surgery.
- It carries a high mortality rate despite available treatments.
Observation:
- A rare case of AE occurred in a 60-year-old diabetic woman with a history of redo mitral valve prosthesis.
- The patient underwent a second redo mitral valve replacement and aortic valve replacement.
- Blood cultures were negative, but the explanted valve revealed Aspergillus flavus.
Findings:
- Aspergillus flavus was identified using conventional and molecular techniques.
- Despite treatment with liposomal amphotericin B, the patient's condition deteriorated, leading to mortality.
- AE can manifest as a late complication following prosthetic valve replacement.
Implications:
- Early diagnosis and prompt, selective antifungal therapy are crucial for managing AE.
- Extended patient follow-up after prosthetic valve surgery is essential.
- Repeating valve-replacement surgeries may be necessary in complex cases.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis IV: Nursing Management
Fungal Phylum Ascomycota
Hemodialysis I: Introduction

